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Abstract
Background: Conventionally the active ingredients in herbal extracts are separated into individual components, by
fractionation, desalting, and followed by high-performance liquid chromatography (HPLC). In this study we have
tried to directly screen water-soluble fractions of herbs with potential active ingredients before purification or
extraction. We propose that the herbal extracts mimicking prostaglandin E1 (PGE1) and E2 (PGE2) can be identified
in the water-soluble non-purified fraction. PGE1 is a potent anti-inflammatory molecule used for treating peripheral
vascular diseases while PGE2 is an inflammatory molecule.
Methods: We used cell-based assays (CytoFluor multi-well plate reader and fluorescence microscopy) in which a
calcium signal was generated by the recombinant EP1 receptor stably expressed in HEK293 cells (human
embryonic kidney). PGE1 and PGE2 were tested for their ability to generate a calcium signal. Ninety-six water
soluble fractions of Treasures of the east (single Chinese herb dietary supplements) were screened.
Results: After screening, the top ten stimulators were identified. The identified herbs were then desalted and the
calcium fluorescent signal reconfirmed using fluorescence microscopy. Among these top ten agonists identified,
seven stimulated the calcium signaling (1-40 μM concentration) using fluorescence microscopy.
Conclusions: Fluorescence microscopy and multi-well plate readers can be used as a target specific method for
screening water soluble fractions with active ingredients at a very early stage, before purification. Our future
work consists of purifying and separating the active ingredients and repeating fluorescence microscopy. Under
ordinary circumstances we would have to purify the compounds first and then test all the extracts from 96
herbs. Conventionally, for screening natural product libraries, the procedure followed is the automated
separation of all constituents into individual components using fractionation and high performance liquid
chromatography. We, however, demonstrated that the active ingredients of the herbal extracts can be tested
before purification using an agonist sensitive, quick and simple cell-based signaling assay for ligands mimicking
the agonists, PGE1 and PGE2.
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Background
The subtype receptors of prostaglandin E (PGE) isomer-
1 (PGE1) and isomer-2 (PGE2) (termed EP1, EP2, EP3
and EP4) are widely distributed and have been exten-
sively studied for their involvement in a variety of can-
cers and stem cell differentiation. Expression of EP1 is
frequently seen in human breast cancers and colon
tumor cells. Nuclear expression of EP1 in human breast
cancers correlates with good prognosis [1,2]. EP (1-4)
subtype receptor mRNAs are generally positively corre-
lated to both COX-1 and COX-2 in tumor tissue, but
not in normal colon [3]. Various studies have shown the
involvement of PGE2 via its EP receptors in growth, dif-
ferentiation and metastasis of cancer; however, there are
no therapeutic ligands available for these receptors
[4-7]. Nevertheless, PGE1 has been shown to have anti-
inflammatory properties as compared to PGE2, which is
a pro-inflammatory mediator. PGE1 has been used ther-
apeutically in peripheral vascular diseases [8-10], and its
importance as a potential ligand in cancer cannot be
overlooked. We chose to test our herbal extracts on the
EP1 subtype receptor since it couples to calcium, which
can be used for detecting the stimulation and inhibition
of the receptor.
Conventionally, for screening natural product libraries,
the procedure followed is the automated separation of
all constituents into individual components. This is
achieved by fractionation of crude extracts from natural
materials using desalting followed by high-performance
liquid chromatography (HPLC). Subsequently, full spec-
troscopic identification is carried out prior to high
throughput screening (HTS) [11]. This process generates
molecules or lead compounds responsible for the biolo-
gical activity found in analyzed extracts. These identified
relevant molecules are further employed in pre-clinical
studies [12]. The structural elucidation is achieved by
mass spectrometry and multi-dimensional nuclear mag-
netic resonance (NMR) spectroscopy, and followed by
the generation of analogues [13].
We, however, propose that the water-soluble and
desalted-soluble fractions of single plant extracts (Treas-
ures of East Single Herbs, Blue Light Inc.) can be used
for tentatively screening potentially active compounds.
These water-soluble fractions can be microscopically
evaluated on specific targets using cell-based assays. The
crude soluble fractions were manually evaluated on the
EP1 subtype receptor for PGE1- and PGE2- mimicking
extracts which could act as agonists. Specifically, this
was achieved by detecting an increase or inhibition of a
calcium signal. This receptor (EP1) is involved in various
cancers and stem cell differentiation [1,2,14]. The recep-
tor activation signal was microscopically detected as
fluorescence using Fluo8-AM dye in HEK293 cells stably
expressing the recombinant EP1. This obviates the need
for separation and purification of extracts before further
testing, and can be accomplished with amazing reliabil-
ity in a much shorter time. In fact, this separation and
purification technique would be a very target-specific,
easy alternative to identify the herbal extract of interest,
which can be later purified by conventional processes
and evaluated again. Potential ligands derived from
these extracts could also be used in cancer therapeutics
and stem cell proliferation and differentiation in the
future.
Methods
The herbal extract granules, taken from Traditional Chi-
nese Medicine (TCM) herbs, were purchased from Tian-
jiang Pharmaceutical Co., LTD, China (distributed by
Blue Light Inc. Ithaca New York). PGE1 and PGE2 were
purchased from Cayman chemicals (Ann Arbor, MI), and
the Fluo8-AM was from ABD-Bioquest (Sunnyvale, CA).
Preparation of Drug Library
The crude drug (2.5 g) was dissolved in hot distilled
water (10 mL). The contents were dissolved by repeated
vortexing. After centrifugation, the soluble supernatants
(5 μL) from 96 individual fractions (water-soluble drug
library) were tested in 96-well plates containing HEK293
cells stably expressing the recombinant EP1 and cell
assays were performed using the CytoFluor Multi-well
plate reader. The stimulators of a calcium signal were
identified as ‘hits’. For confirming the hit compounds, the
remaining supernatants (from original 10 mL) were fil-
tered through a sephadex C18 column to desalt the sam-
ples. The acetone-eluted compounds were dried, weighed
and dissolved in distilled water (0.2 mL) and distributed
into 96-well plates, in which serial one-to-one dilutions
were performed (using distilled water) until obtaining
nearly colorless solutions (desalted drug library) for
further fluorescence microscopy testing using these var-
ied concentrations (1-40 μM) of crude extract. LC/MS
analysis for the herbal extracts revealed that the majority
of molecular masses of the compounds in the herbs were
approximately within the 400-500 Dalton range. Thus
the molecular mass of the individual ingredients in the
soluble fraction was assumed to be 450 Daltons, which is
similar to that of the prostaglandin family.
EP Receptor pcDNA
A pAcSG-EP cDNA cloned by our laboratory was first
subcloned into EcoRI/XhoI sites of pcDNA3.1 (+)
expression vector to generate the plasmid of pcDNA:
human EP1. The pcDNA vector has a Cytomegalovirus
(CMV) promoter and geneticin (G418) as the selection
antibiotic.
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Stable expression of Recombinant EP1 in HEK293 cells
HEK293 cells, placed on 100-mm dishes at a density of 2.0
× 106, were cultured overnight, at 37°C in a humidified 5%
CO2 atmosphere in Dulbecco’s Modified Eagle’s Medium
(DMEM) containing fetal bovine serum (FBS, 10%), anti-
biotics, and antimycotics. The cells were transfected with
the purified cDNA of the recombinant protein (EP1 recep-
tor) by the Lipofectamine 2000 method [15]. Approxi-
mately 48 hours after transfection, the cells were
subcultured and incubated with G418 (selection antibiotic)
for four weeks to generate the EP1 receptor stable cell line.
Western Blot analysis
The HEK293 cells stably expressing the EP1 receptor (EP1
receptor stable cells) were collected by centrifugation
using PBS buffer, pH 7.4. After washing three times, the
pellet was re-suspended in a small volume of the same
buffer. Protein estimation was performed using fluores-
cence spectroscopy. Each protein sample (15 μg) was sepa-
rated by 10% polyacrylamide gel electrophoresis under
denaturing conditions and then transferred to a nitrocellu-
lose membrane. Bands for the EP1 receptor were recog-
nized by the EP1 receptor polyclonal antibody (dilution
1:1000) and visualized with horseradish peroxidase-tagged
goat anti-rabbit secondary antibody (dilution 1:5000). The
EP1 receptor band was detected at 42 kDa for the stable
cell line with the appropriate HEK293 control.
Confocal microscopy
Confocal microscopy was also performed to confirm the
surface receptor expression in the EP1 receptor stable
cell line. The EP1 receptor stable cell line or untrans-
fected HEK293 control cells were grown on cover-slides
that were fixed with 3.7% formaldehyde and blocked
with 10% goat serum and glycine. The cells were gener-
ally permeabilized by 1% saponin and then incubated
with anti-EP1 receptor polyclonal antibody. The bound
antibodies were stained by FITC-labeled (fluorescein iso-
thiocyanate) goat anti-rabbit IgG. The stained cells were
examined by fluorescence confocal microscopy.
Calcium assay
The calcium assay was performed on the HEK293 cells
stably expressing the EP1 receptor using Fluo8-AM dye.
The cells were cultured in 12-well glass-bottom plates
and incubated with Fluo8-AM dye (excitation 490 nm,
emission 525 nm), dissolved in Modified Hank’s buf-
fered salt solution (HBSS, without Calcium and Magne-
sium) containing 10 mM HEPES, pH 7.6, and 0.1%
bovine serum albumin (HBSSHB buffer) for 20 minutes
at 22°C. The cells were then washed 3 times for pertur-
bation with wash buffer (containing HBSSHB with Pro-
benecid Acid (2.5 mM) and Pluronic F-68 (0.1%)), and
incubated for an additional 10 minutes. Afterward, the
ligands PGE1 (1 nM) and PGE2 (100 pM) were individu-
ally tested for a calcium signal in a reaction volume of
1 mL wash buffer using the Nikon Ti-S eclipse micro-
scope (40× objective) with n = 3 experiments [16]. The
cell viability following the experiment was confirmed by
the trypan blue dye exclusion method.
Using the CytoFluor multi-well plate reader for Calcium
assay
The calcium assay was performed in 96-well plates con-
taining the HEK293 cells stably expressing the EP1
receptor and incubated with Fluo8-AM dye as men-
tioned above. Keeping in mind that the calcium signal
duration is approximately 30-40 seconds, the experiment
was performed four wells at a time. The water-soluble
supernatants (5 μL) of the herbal extracts were applied
to the HEK293 cells and the calcium signals were deter-
mined with n = 3 experiments [16]. The untransfected
HEK293 control cells were also tested (data not shown).
The cell viability following the experiment was con-
firmed by the trypan blue dye exclusion method.
Using fluorescence microscopy for Calcium assay
The calcium signal stimulators identified by the above
assay were confirmed by fluorescence microscopy using
the Nikon Ti-S eclipse microscope (40× objective). The
HEK293 cells stably expressing EP1 receptor were cul-
tured in 12-well glass-bottom plates. The calcium assay
(with the Fluo8-AM loading dye and wash buffer) was
performed as described above. A library of desalted sin-
gle herbs was obtained by serially diluting the soluble
fractions in the 96-well plates until nearly colorless frac-
tions were obtained. The calcium signal increase with
potential agonist extracts were identified and confirmed
[16] with n = 3 experiments. The normalized calcium
signal was calculated by subtracting the inherent fluor-
escence of the extract in the background from the cal-
cium signal of the EP1 receptor stable cell line.
Results
Establishing the stable cell line expressing the EP1
receptor
The four subtype receptors which mediate the PGE2-
pathological functions that cause pain, inflammation,
and cancer are the most attractive molecules that can be
used as targets for developing the next generation of
NSAIDs. This is a key step toward obtaining reliable,
simple, and easy biological assays for the receptor sig-
naling mediated by its ligand. High Throughput Screen-
ing (HTS), which requires fewer procedures for the
assays, is the key for successful results. We are currently
using cyclic AMP (cAMP) assays for detection of the
signaling mediated by the prostaglandin I2 receptor (IP)
and prostaglandin E (PGE) isomer-2 (PGE2) subtype
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receptor (EP2) in a manner similar to that described
[17], which required ligand assays and immunoassays
consisting of 5-10 steps. Such procedures are not suita-
ble for cell-based HTS because this system requires
many washes during which the number of cells can be
greatly depleted. However, EP1 signaling that occurs
through increasing intracellular calcium levels is a fast
and reliable measurement. Yet, a simple and quick mea-
surement for the EP1 calcium signaling that is also suita-
ble for cell-based screening has not been established
thus far. To address this concern, we have begun by
generating a cell line that consistently and stably
expresses the EP1 receptor and could be used as a sensi-
tive drug target. This has been accomplished by the
addition of G418 following transfection of the EP1
cDNA into the HEK293 cells, which ultimately yielded
the EP1 receptor stable cell line. High expression levels
of the human EP1 receptor were observed by Western
blot analysis (Figure 1A). The surface expression of the
EP1 on the HEK293 cells was also identified by Confocal
microscopy (Figure 1B). On the other hand, the untrans-
fected HEK293 cells showed no expression.
Establishing a calcium signaling assay for the stable cell
line expressing the human EP1 receptor
After generating the EP1 receptor stable cell line and
confirming the receptor expression, the cells grown in
glass-bottom plates were tested for their ability to
generate a calcium signal. The calcium signal procedure
(using Fluo8-AM) was described above in the methods
section. In comparison to the vector-transfected and
control (untransfected) HEK293 cells which lacked sig-
naling, the stable cell line was very sensitive to dilute
concentrations of PGE1 and PGE2 (Figure 2II.&2IV.)
using Fluo8-AM. This is an extremely important obser-
vation because the non-purified fractions of the desalted
herbs contained multiple ingredients cumulatively
amounting to μM concentrations.
Selection of the Traditional Chinese Medicine (TCM) herbs
for the EP1 screening
The TCM herbs selected for the screening were based on
the TCM principle which favors herbs that are likely to
have clinical implications in the prevention and treat-
ment of inflammation and cancers. The herbal extracts
are manufactured by pharmaceutical companies in main-
land China. The facility follows the GMP (Good Manu-
facturing Practice) standards in China. The single herb
granules (5-folds concentrated) contain less than 1,000
bacteria and less than 100 fungi per gram (no E. coli or
live mites are present) based on the manufacturer’s
Figure 1 Stable expression of Recombinant EP1 in HEK293
cells. (A) Western blot analysis for over-expressed EP1 receptor in
HEK293 cells. HEK293 cells transfected with cDNA of EP1 receptor
(lane 1) or untransfected (lane 2) were solubilized and separated by
10% SDS-PAGE, and then transferred to a nitrocellulose membrane.
The expressed protein was stained with an antibody against EP1. (B)
Immunofluorescence micrographs of HEK293 cells. The general
procedures for the indirect immunostaining are described in the
methods section. In brief, the EP1 receptor stable cell line (Lane 1)
or untransfected HEK293 controls (Lane 2) were grown on cover-
slides. The cells were generally permeabilized by 1% saponin and
then incubated with the anti-EP1 polyclonal rabbit antibody. The
bound antibodies were stained by FITC-labeled goat anti-rabbit IgG.
The stained cells were examined by fluorescence microscopy.
Figure 2 Single cell calcium signal and fluorescence intensity
of the stable EP1 HEK293 cells. (I. & III.) Photomicrographs of
stable EP1 HEK293 cells showing baseline calcium signal (a, c, and
e), and then the calcium signal produced following the addition of
1 nM PGE1 (I.-b) or PGE2 (III.-b), 100 pM PGE1 (I.-d) or PGE2 (III.-d),
and wash buffer (I.-F and III.-f). The calcium signal is also shown for
the untransfected HEK293 cells alone (I-g. and III.-g) and with 1 nM
PGE1 (I.-h) or PGE2 (III.-h). (II. & IV.) Fluorescence intensity of the
stable EP1 HEK293 cells. The stable EP1 HEK293 cells were grown in
glass-bottom plates and incubated with Fluo8-AM dye, followed by
the addition of 1 nM (black upright triangles) PGE1 (II.) or PGE2 (IV.),
100 pM (black squares) PGE1 (II.) or PGE2 (IV.), or wash buffer (II. and
IV., black inverted triangles), and the calcium signals were evaluated
using the Nikon Ti-S eclipse microscope and plotted as fluorescence
intensity. Also shown is the fluorescence intensity of the pcDNA3.1
vector-transfected HEK293 control cells (II. and IV., black circles) and
the untransfected HEK293 control cells in the presence of 1 nM
(black diamonds) PGE1 (II.) or PGE2 (IV.).
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instructions. The water content of each herb is less than
9% (http://www.treasureofeast.com/).
Comparison of calcium signal of 96 herbal extracts on
recombinant EP1 receptor expressed in HEK293 cells
Many of the herbal extracts showed an increase and
decrease in calcium signal using the CytoFluor Multi-
well plate reader. The colored compounds possessed
high intrinsic fluorescence, therefore showed high sig-
nals. The signal from compound alone plus baseline was
subtracted from the total signal. Therefore, some com-
pounds showed high signal, some no signal or negative
signal after subtraction from total signal (Figure 3I.
&3II.). The HEK293 controls did not show significant
increase in fluorescence (data not shown). From the origi-
nal ninety-six compounds, the top ten extracts (Figure 3I.)
that stimulated the calcium signal were chosen as a poten-
tial source for agonists.
Comparison of calcium signal of the top 10 herbal
extracts on recombinant EP1 receptor expressed in
HEK293 cells
The ten identified water-soluble extracts (after desalting)
were serially diluted in 96-well plates (desalted drug
library) until they became nearly colorless solutions. The
colored extracts were producing overwhelming fluores-
cence signals which made microscopy difficult; therefore,
we continued the testing using nearly colorless fractions.
These nearly colorless dilutions of crude extract (1-40 μM)
were tested for their ability to stimulate a calcium signal.
Untransfected HEK293 cells and wash buffer were taken
as the controls, since they showed little to no activity.
The background fluorescence of the extract was sub-
tracted from the cellular signal to give the specific fluor-
escence. Seven out of the ten agonists were able to
stimulate the calcium signal at 1-40 μM concentrations
of crude extract (Figure 4). The EC50 calculated for the
compounds/extracts (using 450 Dalton as an avg. mass
for the herbal ingredients) were as follows: for Com-
pound 7 (2.479 μM), 1 (4.284 nM), 3 (7.941 μM), 2
(8.55 μM), 5 (3.751 μM), 4 (4.14 μM) and 6 (7.937 μM).
Discussion
Morphine was the first pharmacologically active com-
pound isolated from a plant [18] which was followed by
a quest for drugs purified from plant sources. Plant
Extracts or herbal dietary supplements have been used
for ages for their biological properties, such as anti-
inflammation, anti-cancer, etc., relevant for Human Dis-
eases. The first step in screening is the identification of
plant extracts and essential oils which have relevant bio-
medical effects [19-26].
Demonstration of relevant, potential biological activity
on specific molecular targets is followed by the
identification of putative lead compounds. This is done
by various procedures including direct chemical analysis
of plant extracts, gas chromatography/mass spectrome-
try (GC-MS) and high performance liquid chromatogra-
phy/MS (HPLC-MS) [12].
We have, however, generated a convenient agonist-
sensitive cell-based assay to perform the primary preli-
minary screening for potential ligands in herbal extracts.
Receptors, such as the EP1 receptor, which couple to
calcium as a second messenger can be used with Fluo8-
AM dye. Since a very powerful calcium signal is
detected with high sensitivity, the validity of the
approach becomes more significant with high target spe-
cificity. It is advantageous as the supernatants of the
extracts from the soluble fraction can be conveniently
tested for potential hit compounds which can be later
purified.
We suggest that the multi-plate reader can be used
to initially identify the compounds (Figure 3) which
can be diluted and confirmed visually using fluores-
cence microscopy (Figure 4). The only limitation is
that natural sources are likely to have complex struc-
tures with numerous oxygen-containing substituents
and an abundance of centers of stereochemistry [27],
which is not ideal for rapid high-throughput screening
(HTS) of desirable activity of drugs [28]. Nevertheless,
natural products remain an important source of poten-
tial drugs.
Among the un-purified extracts we found seven ago-
nists for the EP1 receptors. Decreased sensitivity due to
color interference was avoided by diluting the herbal
extract until producing nearly colorless concentrations.
The diluted samples for microscopy contained a suffi-
cient amount of active ingredients to stimulate the cal-
cium signal. The diluted sample concentrations were
approximately in the range of 1-40 μM of crude extract.
The treasures of the east are sold as dietary supplements
and consist of well-known herbs from the Chinese
material medica. These herbs are used for a multitude
of problems and consumed orally directly (http://www.
treasureofeast.com/). The EP1 receptor target that we
chose is involved in cancer, and stem cell proliferation
and differentiation [1,2,14]. Antagonists to EP1 receptor
have also been studied for their ability to reduce human
colonic longitudinal muscle contractility in vitro [29].
The ligand, PGE1, is already being used in diseases such
as peripheral vascular diseases with cutaneous ulcers.
Though it is similar to PGE2 in structure, PGE1 pos-
sesses good wound healing properties, which is opposite
to that of PGE2. It is short-acting and is available as
liposomal delivery for cutaneous ulcers [30-32]. Mole-
cules mimicking PGE1 and PGE2 will be further differ-
entiated and evaluated after purification. Also,
antagonists to the inflammatory PGE2 molecule can be
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Figure 3 Normalized calcium signals for the 96 fractions of herbal extracts using the cytofluor multi-well plate reader. The calcium
assay was performed in 96-well plates containing HEK293 cells stably expressing the EP1 receptor and incubated with Fluo8-AM dye. The water
soluble supernatants (5 μL) of the herbal extracts were added to the stable EP1 HEK293 cells and the calcium signals were determined. To
minimize loss of signal, the experiment was performed four wells at a time. The normalized calcium signal was calculated by subtracting the
inherent fluorescence of the extract in the background, where n = 3. The results were presented as four individual graphs showing the extracts,
as indicated. The top 17 extracts with significantly increased calcium signal (moderate ≥5000, high ≥20000) are listed in panel I. The normalized
calcium signals for the remaining herbal extracts (18-96) with little or no activity (≤5000) are shown in panel II.
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Figure 4 Calcium signal for active compounds. The concentration-dependent increase in calcium signal of EP1 stable cell line for the
desalted, diluted potential agonists using fluorescence microscopy are shown. The top 10 water-soluble fractions of herbal extracts were serially
diluted (1:1 using distilled water) in 96-well plates until obtaining nearly colorless solutions ranging from 1-40 μM. The calcium assays were
performed in 12-well glass-bottom plates following the procedures described in Figure 3. Here, the specific fluorescence signal (A.-G., line a) is
shown for the extracts: Extract 7 (A.), Extract 4 (B.), Extract 3 (C.), Extract 5 (D.), Extract 2 (E.), Extract 6 (F.), and Extract 1 (G.). Their respective
controls using HEK293 cells alone (A.-G., line b) and wash buffer (A.-G., line c) are also shown for all seven compounds.
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evaluated for their anti-inflammatory properties. The
dearth of ligands for EP receptors, especially EP1 recep-
tor, as a therapeutic target is what we want to explore.
Similarly, all receptors (such as the EP1), which signal
through calcium as the second messenger can be evalu-
ated for cell-based drug screening. Since the recombi-
nant EP1 receptor stable cell line becomes a very target-
specific approach, its reliability is unquestionable. The
use of the multi-well plate reader followed by fluores-
cence microscopy becomes a very rapid screening tech-
nique. Also, the stable cell lines are able to give strong
calcium signals with as low as picomolar concentrations
of PGE1. This is beneficial as we expect very low con-
centrations of active ingredients in soluble fractions of
herbal extracts. The current difficulty, however, remains
chiefly in modifying our HTS approach for calcium sig-
nal detection using cell-based assays.
Conclusion
With this technique we could screen 96 extracts and
conveniently identify 7 extracts with potential target
specificity. In a multi-well plate reader it becomes diffi-
cult to identify the exact normalized calcium signal for
highly colored compounds as their own fluorescence is
very high giving a higher error margin. The fluorescence
microscope also gradually shows overwhelming fluores-
cence with increasing concentrations of extracts. Our
future work consists of purifying and separating the
active ingredients and repeating fluorescence micro-
scopy. Under ordinary circumstances we would have to
purify the compounds first and then test all the extracts
from 96 herbs. Historically, the screening of natural
materials for biological activity has proven to be better
[33]. Due to the increase in target sites, the pharmaceu-
tical discovery efforts currently favor HTS of pure syn-
thetic compounds [34]. We propose that these diluted
extracts in 96-well plates can be used in HTS using cal-
cium signal detection in cell-based assays. However, the
short duration of the calcium signal is a major limitation
for its applicability in HTS.
Acknowledgements
We thank the graduate students Anita Mohite, Renu Singh, Fady Makram,
Mohamed Nounou, Odelia Ngala, Prema Latha, Ting Zhu, Ayuk Roland, and
Ashley Guillory for helping in the multi-well plate reader screening. The
authors of this report would like to thank Mrs. Vanessa C. Herrera for the
assistance of the manuscript preparation. This work was supported by the
National Institutes of Health [Grants HL56712 and HL79389 (to KHR),
HL100807 (to RD and KHR)] and the American Heart Association [Grant
10GRNT4470042 (to KHR)].
Author details
1Centre for Experimental Therapeutics and Pharmacoinformatics, Department
of Pharmacological and Pharmaceutical Sciences, College of Pharmacy,
University of Houston, Houston, Texas 77004 USA. 2TR Acupuncture and
Herbal Clinic, Houston, TX 77005 USA.
Authors’ contributions
AJC carried out the calcium signaling assays, participated in analysis and the
design of the experiments and drafted the manuscript. PK prepared the
herbal drug library, helped in the calcium signaling assays and participated
in analysis of the data. KT and KHR designed and guided the study and
helped to correct the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 October 2010 Accepted: 7 February 2011
Published: 7 February 2011
References
1. O’Callaghan G, Kelly J, Shanahan F, Houston A: Prostaglandin E2 stimulates
Fas ligand expression via the EP1 receptor in colon cancer cells. Br J
Cancer 2008, 99:502-512.
2. Thorat MA, Morimiya A, Mehrotra S, Konger R, Badve SS: Prostanoid
receptor EP1 expression in breast cancer. Mod Pathol 2008, 21:15-21.
3. Gustafsson A, Hansson E, Kressner U, Nordgren S, Andersson M, Wang W,
Lönnroth C, Lundholm K: EP1-4 subtype, COX and PPAR gamma receptor
expression in colorectal cancer in prediction of disease-specific
mortality. Int J Cancer 2007, 121:232-240.
4. Subbaramaiah K, Hudis C, Chang SH, Hla T, Dannenberg AJ: EP2 and EP4
receptors regulate aromatase expression in human adipocytes and
breast cancer cells. Evidence of a BRCA1 and p300 exchange. J Biol
Chem 2008, 283:3433-3444.
5. Chang SH, Ai Y, Breyer RM, Lane TF, Hla T: The prostaglandin E2 receptor
EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
Cancer Res 2005, 65:4496-4499.
6. Shoji Y, Takahashi M, Kitamura T, Watanabe K, Kawamori T, Maruyama T,
Sugimoto Y, Negishi M, Narumiya S, Sugimura T, Wakabayashi K: Down
regulation of prostaglandin E receptor subtype EP3 during colon cancer
development. Gut 2004, 53:1151-1158.
7. Chell SD, Witherden IR, Dobson RR, Moorghen M, Herman AA,
Qualtrough D, Williams AC, Paraskeva C: Increased EP4 receptor expression
in colorectal cancer progression promotes cell growth and anchorage
independence. Cancer Res 2006, 66:3106-3113.
8. Miyauchi Y: Treatment of the peripheral vascular diseases with
prostaglandin. Nippon Rinsho 1994, 52:2182-2186.
9. Murota H, Kotobuki Y, Umegaki N, Tani M, Katayama I: New aspect of anti-
inflammatory action of lipo-prostaglandin E1 in the management of
collagen diseases-related skin ulcer. Rheumatol Int 2008, 28:1127-1135.
10. Sobota RM, Müller PJ, Heinrich PC, Schaper F: Prostaglandin E1 inhibits IL-
6-induced MCP-1 expression by interfering specifically in IL-6-dependent
ERK1/2, but not STAT3, activation. Biochem J 2008, 412(1):65-72.
11. Bugni TS, Richards B, Bhoite L, Cimbora D, Harper MK, Ireland CM: Marine
Natural Product Libraries for High-Throughput Screening and Rapid
Drug Discovery. J Nat Prod 2008, 71:1095-1098.
12. Nicolis E, Lampronti I, Dechecchi MC, Borgatti M, Tamanini A, Bianchi N,
Bezzerri V, Mancini I, Giri MG, Rizzotti P, Gambari R, Cabrini G: Pyrogallol, an
active compound from the medicinal plant Emblica officinalis, regulates
expression of pro-inflammatory genes in bronchial epithelial cells. Int
Immunopharmacol 2008, 8:1672-1680.
13. Lang G, Mayhudin NA, Mitova MI, Sun L, van der Sar S, Blunt JW, Cole AL,
Ellis G, Laatsch H, Munro MH: Evolving Trends in the Dereplication of
Natural Product Extracts: New Methodology for Rapid, Small-Scale
Investigation of Natural Product Extracts. J Nat Prod 2008, 71:1595-1599.
14. Chen L, Zhang W, Yue H, Han Q, Chen B, Shi M, Li J, Li B, You S, Shi Y,
Zhao RC: Effects of Human Mesenchymal Stem Cells on the
Differentiation of Dendritic Cells from CD34 Cells. Stem Cells And
Development 2007, 16:719-731.
15. Hatae N, Yamaoka K, Sugimoto Y, Negishi M, Ichikawa A: Augmentation of
receptor-mediated adenylyl cyclase activity by Gi-coupled prostaglandin
receptor subtype EP3 in a Gbetagamma subunit-independent manner.
Biochem Biophys Res Commun 2002, 290:162-168.
16. Gee KR, Brown KA, Chen WU, Bishop-Stewart J, Gray D, Johnson I: Chemical
and physiological characterization of fluo-4 Ca(2+)-indicator dyes. Cell
Calcium 2000, 27:97-106.
Chillar et al. BMC Complementary and Alternative Medicine 2011, 11:11
http://www.biomedcentral.com/1472-6882/11/11
Page 8 of 9
17. Golla R, Seethala RA: Homogeneous Enzyme Fragment Complementation
Cyclic AMP Screen for GPCR Agonists. J Biomol Screen 2002, 7:515-525.
18. Hamilton GR, Baskett TF: In the arms of morpheus: the development of
morphine for postoperative pain relief. Can J Anaesth 2000, 47:367-374.
19. Cooper R, Morre’ DJ, Morre’ DM: Medicinal benefits of green tea, part II:
review of anticancer properties. J Altern Complement Med 2005,
11:639-652.
20. Vieira JRC, de Souza IA, do Nascimento SC, Leite SP: Indigoferasuffruticosa:
an alternative anticancer therapy. eCAM 2007, 4:355-359.
21. Lambertini E, Piva R, Khan MT, Lampronti I, Bianchi N, Borgatti M,
Gambari R: Effects of extracts from Bangladeshi medicinal plants on in
vitro proliferation of human breast cancer cell lines andexpression of
estrogen receptor alpha gene. Int J Oncol 2004, 24:419-423.
22. Khan MT, Ather A, Thompson KD, Gambari R: Extracts and molecules from
medicinal plants against herpes simplex viruses. Antiviral Res 2005,
67:107-119.
23. Tohda C, Nakayama N, Hatanaka F, Komatsu K: Comparison of anti-
inflammatory activities of six Curcuma rhizomes: a possible
curcuminoid-independent pathway mediated by Curcuma phaeocaulis
extract. eCAM 2006, 3:255-260.
24. Chun S, Jee S, Lee S, Park SJ, Lee J, Kim S: Anti-Inflammatory activity of
the methanol extract of moutan cortex in LPS-activated Raw264.7 cells.
eCAM 2007, 4:327-333.
25. Lee KH, Kim AJ, Choi EM: Antioxidant and anti-inflammatory activity of
pine pollen extract in vitro. Phytother Res 2009, 23:41-48.
26. Wu M, Gu Z: Screening of bioactive compounds from moutan cortex
and their anti-inflammatory activities in rat synoviocytes. eCAM 2009,
6:57-63.
27. Koehn FE, Carter GT: The evolving role of natural products in drug
discovery. Nat Rev Drug Discov 2005, 4:206-220.
28. Butler MS: The Role of Natural Product Chemistry in Drug Discovery.
J Nat Prod 2004, 67:2141-2153.
29. Smid SD, Svensson KM: Inhibition of cyclooxygenase-2 and EP1 receptor
antagonism reduces human colonic longitudinal muscle contractility in
vitro. Prostaglandins Other Lipid Mediat 2009, 88:117-121.
30. Mizushima Y, Yanagawa A, Hoshi A: Prostaglandin E1 is more effective,
when incorporated in lipid microspheres, for treatment of peripheral
vascular diseases in man. J Pharm Pharmacol 1983, 35:666-667.
31. Toyota T, Hirata Y, Ikeda Y, Matsuoka K, Sakuma A, Mizushima Y: Lipo-PGEl
A New Lipid-Encapsulated Preparation Of Prostaglandin El: Placebo-And
Prostaglandin El-Controlled Multicentric Trials In Patients With Diabetic
Neuropathy And Leg Ulcers. Prostaglandins 1993, 46:453-468.
32. Rie I, Mitsuko T, Jun T, Aki K, Kayo M, Yutaka M: Marked hypotensive and
blood flow-increasing effects of a new lipo-PGE (lipo-AS013) due to
vascular wall targeting. Journal of Controlled Release 2001, 71:157-164.
33. Weissman KJ, Leadlay PF: Combinatorial biosynthesis of reduced
polyketides. Nat Rev Microbiol 2005, 3:925-936.
34. Newman DJ: Natural Products as Leads to Potential Drugs: An Old
Process or the New Hope for Drug Discovery? J Med Chem 2008,
51:2589-2599.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6882/11/11/prepub
doi:10.1186/1472-6882-11-11
Cite this article as: Chillar et al.: An agonist sensitive, quick and simple
cell-based signaling assay for determination of ligands mimicking
prostaglandin E2 or E1 activity through subtype EP1 receptor: Suitable
for high throughput screening. BMC Complementary and Alternative
Medicine 2011 11:11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Chillar et al. BMC Complementary and Alternative Medicine 2011, 11:11
http://www.biomedcentral.com/1472-6882/11/11
Page 9 of 9
